Budget Impact Analysis of <i>EGFR</i> Mutation Liquid Biopsy for First- and Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer in Greece
Within the European Union, Greece has the highest incidence of lung cancer among people under 45 years of age. Epidermal growth factor receptor (<i>EGFR</i>) tyrosine kinase inhibitors are indicated for the treatment of patients with <i>EGFR</i> mutation-positive metastatic n...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/6/429 |